India’s Central Drugs Standard Control Organisation (CDSCO) has released new guidelines that allow the compounding of minor drug-related violations, marking a significant step toward faster enforcement, improved compliance, and reduced litigation within the pharmaceutical ecosystem. The guidelines outline specific categories of procedural and technical lapses that
As India approaches Budget 2026, the conversation is shifting from growth for growth’s sake to growth that creates real value for citizens, industries, and the global economy. India has already demonstrated scale: world-class digital infrastructure, expanding manufacturing capability, a young workforce, and rising innovation. The
Max Healthcare has announced a strategic partnership with The Learning Lab to accelerate capacity building, strengthen research capabilities, and advance knowledge-sharing across the healthcare ecosystem. The collaboration aims to equip clinicians, healthcare leaders, and allied professionals with future-ready skills while fostering innovation driven research programs. Through
Company launches ‘Fit Raho, Hit Raho’ campaign to drive lifestyle adoption and accelerate category expansion across urban and rural markets Leeford Healthcare Limited, one of India’s leading Healthcare companies, has announced a strategic investment of INR 200 crore in the next three years to rapidly scale
Non-Obstructive Azoospermia (NOA) is one of the most severe and challenging forms of male infertility, where there is zero sperm in the semen. It affects only a small percentage of men and is usually linked to testicular trauma, childhood testicular infection, torsion testis, exposure to
Granules Pharmaceuticals, Inc., a wholly owned subsidiary of Granules India Limited, has received Tentative Approval (TA) from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for generic Amphetamine Extended-Release Tablets in strengths of 5 mg, 10 mg, 15 mg,
Dr. Shalini Dubey, Medical Affairs Manager, Iberia Pharmaceuticals For years, sunscreen was just another cosmetic step. People chose between SPF 15, 30, or 50, applied a layer, and assumed they were protected. But skincare science has moved far ahead: sunscreen is not a basic film on
Dr. Lal PathLabs Limited (“Dr. Lal PathLabs”), one of India’s most trusted diagnostics brands, today announced the launch of Sovaaka, its new-age Diagnostic Experience Centre in Gurugram. The launch event was graced by the Hon’ble Chief Minister of Haryana, Shri Nayab Singh Saini. Built on the philosophy
In a landmark development for mental health treatment, the United States Food and Drug Administration (US FDA) has approved the first at-home medical device designed to help manage symptoms of depression. The approval represents a major milestone in digital therapeutics and neuromodulation, offering patients a
In a significant milestone for indigenous medical technology, India’s homegrown stroke treatment device has successfully cleared clinical trials, paving the way for wider clinical adoption and improved access to advanced neurovascular care across the country. The breakthrough underscores India’s growing capability to design, develop, and
